Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma
-
- SHIMADA Keiji
- Department of Pathology, Nara Medical University School of Medicine
-
- NAKAMURA Mitsutoshi
- Department of Pathology, Nara Medical University School of Medicine
-
- DE VELASCO Marco A.
- Department of Urology, Kinki University School of Medicine
-
- TANAKA Motoyoshi
- Department of Urology, Kinki University School of Medicine
-
- OUJI Yukiteru
- Department of Parasitology, Nara Medical University School of Medicine
-
- MIYAKE Makito
- Department of Urology, Nara Medical University School of Medicine
-
- FUJIMOTO Kiyohide
- Department of Urology, Nara Medical University School of Medicine
-
- HIRAO Kazuya
- Department of Urology, Hirao Hospital
-
- KONISHI Noboru
- Department of Pathology, Nara Medical University School of Medicine
Search this Article
Author(s)
-
- SHIMADA Keiji
- Department of Pathology, Nara Medical University School of Medicine
-
- NAKAMURA Mitsutoshi
- Department of Pathology, Nara Medical University School of Medicine
-
- DE VELASCO Marco A.
- Department of Urology, Kinki University School of Medicine
-
- TANAKA Motoyoshi
- Department of Urology, Kinki University School of Medicine
-
- OUJI Yukiteru
- Department of Parasitology, Nara Medical University School of Medicine
-
- MIYAKE Makito
- Department of Urology, Nara Medical University School of Medicine
-
- FUJIMOTO Kiyohide
- Department of Urology, Nara Medical University School of Medicine
-
- HIRAO Kazuya
- Department of Urology, Hirao Hospital
-
- KONISHI Noboru
- Department of Pathology, Nara Medical University School of Medicine
Journal
-
- Cancer Sci
-
Cancer Sci 101(1), 155-160, 2010-01-10
References: 31
-
1
- Syndecan-1 is a multifunctional regulator of myeloma pathobiology : control of tumor cell survival, growth, and bone cell differentiation
-
DHODAPKAR MV
Blood 91, 2679-2688, 1998
Cited by (1)
-
2
- Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
-
MAHTOUK K
Oncogene 25, 7180-7191, 2006
Cited by (1)
-
3
- The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy
-
YANG Y
Blood 110, 2041-2048, 2007
Cited by (1)
-
4
- Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
-
NIKOLOVA V
Carcinogenesis 30, 397-407, 2009
Cited by (1)
-
5
- A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression
-
SHIMADA K
Cancer Res 69, 3157-3164, 2009
Cited by (1)
-
6
- FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
-
JEBAR AH
Oncogene 24, 5218-5225, 2005
Cited by (1)
-
7
- Genetic alterations in urothelial bladder carcinoma : an updated review
-
MHAWECH-FAUCEGLIA P
Cancer 106, 1205-1216, 2006
Cited by (1)
-
8
- Characteristics of invasive bladder cancers : histological and molecular markers
-
LIEBERT M
Semin Urol Oncol 14, 62-72, 1996
Cited by (1)
-
9
- C-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas
-
SHIMADA K
Am J Pathol 171, 1003-1012, 2007
Cited by (1)
-
10
- Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9
-
SHIMADA K
Urology 68, 891-e7, 2006
Cited by (1)
-
11
- Plasmacytoid urothelial carcinoma : detailed analysis of morphology with clinicopathologic correlation in 17 cases
-
NIGWEKAR P
Am J Surg Pathol 33, 417-424, 2009
Cited by (1)
-
12
- A case of urothelial carcinoma with triple variants featuring nested, plasmacytoid, and lipoid cell morphology
-
SHIMADA K
Diagn Cytopathol 37, 272-276, 2009
Cited by (1)
-
13
-
14
- Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression
-
SHIMADA K
J Pathol 206, 423-432, 2005
Cited by (1)
-
15
- Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas
-
KONISHI N
Am J Pathol 160, 1207-1214, 2002
Cited by (1)
-
16
- GFP image analysis in the mouse orthotopic bladder cancer model
-
DE VELASCO MA
Oncol Rep 20, 543-547, 2008
Cited by (1)
-
17
- Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation
-
SU G
Cancer Res 68, 9558-9565, 2008
Cited by (1)
-
18
- Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor
-
BEAUVAIS DM
J Exp Med 206, 691-705, 2009
Cited by (1)
-
19
- c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells
-
DAY TW
Biochem Pharmacol 76, 1694-1704, 2008
Cited by (1)
-
20
- The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways
-
KATAOKA T
Curr Biol 10, 640-648, 2000
Cited by (1)
-
21
- Specific positive and negative effects of FLIP on cell survival in human prostate cancer
-
SHIMADA K
Carcinogenesis 27, 1349-1357, 2006
Cited by (1)
-
22
- MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L)
-
LI W
Cancer Res 67, 2247-2255, 2007
Cited by (1)
-
23
- Molecular cytogenetics of bladder cancer progression
-
SAUTER G
Eur Urol 33(Suppl 4), 9-10, 1998
Cited by (1)
-
24
- Functions of cell surface heparan sulfate proteoglycans
-
BERNFIELD M.
Annu Rev Biochem 68, 729-777, 1999
DOI Cited by (39)
-
25
- A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1
-
WIJDENES J.
Br J Haematol. 94, 318-323, 1996
DOI Cited by (7)
-
26
- Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
-
DERKSEN PW
Blood 99, 1405-1410, 2002
DOI Cited by (4)
-
27
- <no title>
-
HANAHAN D.
Cell 100, 57-70, 2000
DOI Cited by (103)
-
28
- Urothelial tumorigenesis : a tale of divergent pathways
-
WU XR.
Nature Res Cancer 5, 713-725, 2005
DOI Cited by (2)
-
29
- Inhibition of death receptor signals by cellular FLIP
-
IRMLER M.
Nature 388, 190-195, 1997
DOI Cited by (33)
-
30
- <no title>
-
SHAULIAN E.
Oncogene 20, 2390-2400, 2001
DOI Cited by (16)
-
31
- <no title>
-
SHAULIAN E
Nat. Cell Biol. 4, 131-136, 2002
DOI Cited by (12)
Cited by: 2
-
1
- Recent progress of nucleic acid delivery system mediated by atelocollagen [in Japanese]
-
MAKITA Naoki , NAGAHARA Shunji
Drug Delivery System 25(6), 607-614, 2010-11-25
J-STAGE Ichushi Web References (32) Cited by (1)
-
2
- A case of urothelial carcinoma, plasmacytoid variant with peritoneal dissemination [in Japanese]
-
KOZAKAI Tomonori , NISHIZAWA Kazuyo , ISHIDA Akiko , IIZUKA Keiji , OTA Hiroyoshi
The Journal of the Japanese Society of Clinical Cytology 52(1), 17-22, 2013-01-22
J-STAGE Ichushi Web References (15)